Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ADP ribosylation factor like GTPase 17B | 0.780 | 0.269 | 0.34 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ADP ribosylation factor like GTPase 3 | 0.603 | 0.615 | 1.4E-03 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2017 | 2018 | ||||||||
|
adrenoceptor beta 1 | 0.555 | 0.769 | 2.9E-06 |
|
phenotype | 0.100 | None | 1.000 | 4 | 1 | 2016 | 2019 | ||||||||
|
AE binding protein 2 | 0.821 | 0.192 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
alcohol dehydrogenase 1B (class I), beta polypeptide | 0.502 | 0.846 | 9.9E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
aldehyde dehydrogenase 1 family member A2 | 0.578 | 0.692 | 0.36 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
aldo-keto reductase family 1 member B10 | 0.546 | 0.769 | 7.6E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ALG9 alpha-1,2-mannosyltransferase | 0.644 | 0.654 | 6.4E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
androgen receptor regulated long noncoding RNA 1 | 0.890 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
angiopoietin 2 | 0.410 | 0.846 | 0.83 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2017 | 2017 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
phenotype | 0.100 | None | 1.000 | 5 | 4 | 2016 | 2019 | ||||||||
|
anillin actin binding protein | 0.644 | 0.500 | 0.14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
ankyrin 3 | 0.578 | 0.654 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
ankyrin repeat and SOCS box containing 15 | 0.792 | 0.231 | 1.8E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ankyrin repeat domain 13A | 2.1E-04 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | ||||||||||
|
APOA1 antisense RNA | 0.760 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||||||
|
apolipoprotein A1 | 0.429 | 0.885 | 5.5E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
apolipoprotein H | 0.563 | 0.769 | 1.6E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
apolipoprotein L domain containing 1 | 0.890 | 0.192 | 1.2E-04 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2018 | 2019 | ||||||||
|
apoptosis associated tyrosine kinase | 0.792 | 0.154 | 0.21 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
AQP4 antisense RNA 1 | 0.751 | 0.577 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
arginine and serine rich coiled-coil 1 | 0.650 | 0.462 | 7.5E-05 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2019 |